Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of Oxytocin on Familial Interactions

Next Previous
Trial Profile

Effects of Oxytocin on Familial Interactions

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 11 Dec 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Oxytocin (Primary)
  • Indications Pervasive child development disorders; Schizophrenia
  • Focus Therapeutic Use
  • Acronyms DOS

Most Recent Events

  • 04 Dec 2018 Status changed from recruiting to completed.
  • 09 Feb 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov.
  • 26 May 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2015, according to ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top